HUTCHINSON, Kan.--(BUSINESS WIRE)--June 21, 2004--HEE Corporation - (OTC - PK - HCCF) would like to announce that Ron Brooks and Stan Casad will be departing tomorrow for the United Arab Emirates to begin receiving the company's first documented treatments for the potential cure of Type II Diabetes. Mr. Brooks and Mr. Casad will be under the care of the physician and developer of this revolutionary homeopathic treatment. Excitement is soaring as these men lead the way for tens of millions of potential patients. Sufferers of Type II Diabetes are waiting for an answer to this debilitating and deadly disease, and HEE Corporation hopes to have it. This is the first step in determining that the treatment, that HEE Corporation has the exclusive worldwide distribution rights for, is as effective as indicated. Keep posted to our Web site for more breaking information as it becomes available.
ABOUT HEE CORPORATION

The HEE Corporation was founded for the purpose of marketing a new and extremely promising treatment for Type II Diabetes. HEE has acquired the worldwide distribution rights for this diabetic treatment. Just in the United States Type II Diabetes has reached epidemic levels with 18.2 million confirmed cases and an estimated 5 million cases that are undiagnosed. Hundreds of billions of dollars worldwide is spent each year on the treatment of this disease.

For more information about the Company contact Shannon @ 620-663-3333 or visit our Web site at www.hee-corp.com.

NOTE: Safe Harbor for Forward-Looking Statements--Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that may cause the company's actual results in the future to differ materially from forecasted results. These risks and uncertainties include, among other things, volatility of prices, product demand, market compensation and risk inherent in the company's international operations.

--------------------------------------------------------------------------------
Contact:
HEE Corporation
Shannon Meyer, 620-663-3333
www.hee-corp.com

--------------------------------------------------------------------------------
Source: HEE Corporation

------------------
Due Da Due......But Be Quick About It!!!!!

------------------
Due Da Due......But Be Quick About It!!!!!

HUTCHINSON, Kan.--(BUSINESS WIRE)--May 25, 2004--HEE Corporation - (OTC - PK - HCCF) would like to give the public a better understanding of the method of this treatment against Type II Diabetes.
This treatment for Type II Diabetes was derived from plants currently grown only in the Asian Region. The herbs are processed into tablets that are taken 2 times a day for 8 weeks and then once a month to maintain the pancreas. The treatment will be administered through licensed clinics and practitioners throughout the World.

It is estimated that there are 171 million people worldwide who suffer from Type II Diabetes. By the year 2030 the number of Type II Diabetics will escalate to and estimated 360 million according to the World Health Organization. We are very excited about the prospects for helping millions of people suffering from this possibly debilitating and deadly disease.

ABOUT HEE CORPORATION

The Hee Corporation was founded for the purpose of marketing a new and extremely promising treatment for Type II Diabetes. This treatment was developed in South West Asia. HEE has acquired the worldwide distribution rights for this diabetic treatment. Just in the United States type II Diabetes has reached epidemic levels with 18.2 million confirmed cases and an estimated 5 million cases that are undiagnosed. Hundreds of billions of dollars world wide is spent each year on the treatment of this disease.

For more information about the Company contact Shannon @620-663-3333 or visit our web site at www.hee-corp.com.

NOTE: Safe Harbor for Forward-Looking Statements--Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that may cause the company's actual results in the future to differ materially from forecasted results. These risks and uncertainties include, among other things, volatility of prices, product demand, market compensation and risk inherent in the company's international operations.

--------------------------------------------------------------------------------
Contact:
HEE Corporation
Shannon, 620-663-3333
www.hee-corp.com

--------------------------------------------------------------------------------
Source: HEE Corporation

------------------
Due Da Due......But Be Quick About It!!!!!

With the news after the close, think I would be chasing it tommorow?

TORONTO, March 25 /PRNewswire-FirstCall/ - The Board of Directors of HEE Corporation -- (OTC - PK - HCCF) is extremely pleased to announce that the company has signed to appear on Health Journal Television, in April, 2004, hosted by General Alexander Haig.
HJTV is a magazine style show that features up and coming technologies pertaining to our health care and how it will impact the future of health care. They are doing a series on Diabetes starting next month.

HJTV is seen on the following networks by 84 million television households:

CNBC - 84 Million Cable and 58 Million DIRECTV and Dish Network
Bravo - 70 Million Cable and 58 Million DIRECTV and Dish Network
Tech TV - 40 Million Cable and 58 Million DIRECTV and Dish Network
International: Hong Kong, Canada
650 Hospitals: Health and Science Television Network (HSTN)
750 Long Term Care Facilities: Long Term Care Network (LTCN)
9 Top Medical Universities/Libraries
30+ Business Universities
Business Travelers on thousands of International flights: United Airlines
75 Million PC users: Broadcast.yahoo.com
____________________________________________

HEE Corporation Announces That It Has Agreed to the Location to Test the Diabetes Treatment
Thursday May 6, 2:46 pm ET

HUTCHINSON, KS--(BUSINESS WIRE)--May 6, 2004--The Board of Directors of HEE Corporation - (OTC - PK - HCCF) is extremely pleased to announce that the company has agreed to have the first group tested at Northwestern University in Oregon.
Northwestern is the leading university in the nation in the study of homeopathic medicine.

In addition the company is working and securing the necessary documents, visa's and travel papers to enable the Doctor to come and stay in the United States to supervise the tests at Northwestern. This process is taking longer than anticipated but all parties are hopeful that the approvals will be coming in short order.

_____________________________________________

HEE Corp. Moves Into New Corporate Headquarters
Monday May 10, 3:45 pm ET

HUTCHINSON, Kan.--(BUSINESS WIRE)--May 10, 2004--The Board of Directors of HEE Corporation (OTC:HCCF.PK - News) is very pleased to announce that the company has moved into their newly and extensively remodeled corporate headquarters. Construction and renovation was completed May 5th, 2004 with the move taking place May 7th, 2004. The corporate offices will serve as liaison between the main Kansas City Headquarters and the board of directors as well as serving as an interim call handling facilities for the hundreds of calls and enquiries the company receives.
Please view our Web site for pictures of the new facility.

_____________________________________________

HEE Corp. Contracts AAT Investments
Tuesday May 18, 11:40 am ET

HUTCHINSON, Kan.--(BUSINESS WIRE)--May 18, 2004--The Board of Directors of HEE Corporation - (OTC - PK - HCCF) has announced completion of contract negations with AAT Investments, Inc. The contract with AAT Investments Inc. provides assistance in establishing a nationwide network of treatment clinics. Mr. Ronald D. Brooks, President of AAT Investment, Inc. will personally provide consulting services to HEE Corporation. He will be working in conjunction with the HEE Corp. staff in setting the logistics required for setting up nationwide distribution and treatment centers.

_____________________________________________

HEE Corp. To Begin In-House Initial Treatments
Thursday May 20, 4:13 pm ET

HUTCHINSON, Kan.--(BUSINESS WIRE)--May 20, 2004--The Board of Directors of HEE Corporation - (OTC - PK - HCCF) has authorized initial in house testing to HEE Corp. employees and affiliates to start early June 2004. The following participants all have Type II Diabetes and are all in different stages of the disease. Ronald D. Brooks, President of AAT Investments, Inc. has been under doctor's care with Type II Diabetes for the past 9 years. Frank Stuckey, CFO of HEE Corp has been under doctor's supervision for the past 5 years. Stan Casad, President of Medicor Corp. of Houston, Texas has had diabetes for over 2 years. All three individuals will be departing for the Middle East in early June to be under the personal care of the developer of the treatment.
ABOUT HEE CORPORATION

The HEE Corporation was founded for the purpose of marketing a new and extremely promising treatment for Type II Diabetes. This treatment was developed in South West Asia. HEE has acquired the worldwide distribution rights for this diabetic treatment. Just in the United States, Type II Diabetes has reached epidemic levels with 18.2 million confirmed cases and an estimated 5 million cases that are undiagnosed. Hundreds of billions of dollars world wide are spent each year on the treatment of this disease.

For more information about the Company contact Shannon Meyer @620-663-3333 www.hee-corp.com.

NOTE: Safe Harbor for Forward-Looking Statements--Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that may cause the company's actual results in the future to differ materially from forecasted results. These risks and uncertainties include, among other things, volatility of prices, product demand, market compensation and risk inherent in the company's international operations.

--------------------------------------------------------------------------------
Contact:
HEE Corporation
Shannon Meyer, 620-663-3333
www.hee-corp.com.

--------------------------------------------------------------------------------
Source: HEE Corporation
_____________________________________________

PRICES

Date Open High Low Close Volume Adj Close*
17-Jun-04 0.16 0.16 0.16 0.16 0 0.16
16-Jun-04 0.17 0.17 0.17 0.17 0 0.17
15-Jun-04 0.16 0.16 0.16 0.16 0 0.16
14-Jun-04 0.17 0.17 0.17 0.17 0 0.17
10-Jun-04 0.17 0.17 0.17 0.17 0 0.17
9-Jun-04 0.12 0.12 0.12 0.12 0 0.12
8-Jun-04 0.12 0.12 0.12 0.12 0 0.12
7-Jun-04 0.12 0.12 0.12 0.12 0 0.12
4-Jun-04 0.12 0.12 0.12 0.12 0 0.12
3-Jun-04 0.12 0.12 0.12 0.12 0 0.12
2-Jun-04 0.12 0.12 0.12 0.12 0 0.12
1-Jun-04 0.14 0.14 0.14 0.14 0 0.14
28-May-04 0.14 0.14 0.14 0.14 0 0.14
27-May-04 0.13 0.13 0.13 0.13 0 0.13
26-May-04 0.13 0.13 0.13 0.13 0 0.13
25-May-04 0.12 0.12 0.12 0.12 0 0.12
24-May-04 0.15 0.15 0.15 0.15 0 0.15
21-May-04 0.29 0.29 0.29 0.29 0 0.29
20-May-04 0.15 0.15 0.15 0.15 0 0.15
19-May-04 0.39 0.39 0.39 0.39 0 0.39
18-May-04 0.39 0.39 0.39 0.39 0 0.39
17-May-04 0.41 0.41 0.41 0.41 0 0.41
14-May-04 0.41 0.41 0.41 0.41 0 0.41
13-May-04 0.42 0.42 0.42 0.42 0 0.42
12-May-04 0.39 0.39 0.39 0.39 0 0.39
11-May-04 0.40 0.40 0.40 0.40 0 0.40
10-May-04 0.40 0.40 0.40 0.40 0 0.40
7-May-04 0.40 0.40 0.40 0.40 0 0.40
6-May-04 0.35 0.35 0.35 0.35 0 0.35
5-May-04 0.36 0.36 0.36 0.36 0 0.36
4-May-04 0.38 0.38 0.38 0.38 0 0.38
3-May-04 0.47 0.47 0.47 0.47 0 0.47
30-Apr-04 0.47 0.47 0.47 0.47 0 0.47
29-Apr-04 0.47 0.47 0.47 0.47 0 0.47
28-Apr-04 0.47 0.47 0.47 0.47 0 0.47
27-Apr-04 0.47 0.47 0.47 0.47 0 0.47
26-Apr-04 0.47 0.47 0.47 0.47 0 0.47
23-Apr-04 0.47 0.47 0.47 0.47 0 0.47
22-Apr-04 0.50 0.50 0.50 0.50 0 0.50
21-Apr-04 0.50 0.50 0.50 0.50 0 0.50
20-Apr-04 0.50 0.50 0.50 0.50 0 0.50
19-Apr-04 0.40 0.40 0.40 0.40 0 0.40
16-Apr-04 0.40 0.40 0.40 0.40 0 0.40
15-Apr-04 0.50 0.50 0.50 0.50 0 0.50
14-Apr-04 0.50 0.50 0.50 0.50 0 0.50
13-Apr-04 0.64 0.64 0.64 0.64 0 0.64
12-Apr-04 0.55 0.55 0.55 0.55 0 0.55
8-Apr-04 0.55 0.55 0.55 0.55 0 0.55
7-Apr-04 0.55 0.55 0.55 0.55 0 0.55
6-Apr-04 0.65 0.65 0.65 0.65 0 0.65
5-Apr-04 0.65 0.65 0.65 0.65 0 0.65
2-Apr-04 0.64 0.64 0.64 0.64 0 0.64
1-Apr-04 0.64 0.64 0.64 0.64 0 0.64
31-Mar-04 0.64 0.64 0.64 0.64 0 0.64
30-Mar-04 0.59 0.59 0.59 0.59 0 0.59
29-Mar-04 0.60 0.60 0.60 0.60 0 0.60
26-Mar-04 0.60 0.60 0.60 0.60 0 0.60
25-Mar-04 0.60 0.60 0.60 0.60 0 0.60
24-Mar-04 0.60 0.60 0.60 0.60 0 0.60
23-Mar-04 0.64 0.64 0.64 0.64 0 0.64
22-Mar-04 0.56 0.56 0.56 0.56 0 0.56
19-Mar-04 0.63 0.63 0.63 0.63 0 0.63
18-Mar-04 0.62 0.62 0.62 0.62 0 0.62
17-Mar-04 0.62 0.62 0.62 0.62 0 0.62
16-Mar-04 0.61 0.61 0.61 0.61 0 0.61
15-Mar-04 0.58 0.58 0.58 0.58 0 0.58

------------------
Due Da Due......But Be Quick About It!!!!!

DaDog

52-Hi $5.00
52-Lo 0.11

Closing Bid/Ask 0.14/0.155
Last Trans. Price 0.14

Trades: 32 Volume: 374,900

------------------
Due Da Due......But Be Quick About It!!!!!

DaDog

------------------
Due Da Due......But Be Quick About It!!!!!

HUTCHINSON, Kan.--(BUSINESS WIRE)--HCCF--
HEE Corporation - (OTC - PK - HCCF) would like to
announce that Ron Brooks and Stan Casad have arrived in the United
Arab Emirates and have begun to receive the company's first documented
treatments for the potential cure of Type II Diabetes. Mr. Brooks and
Mr. Casad are under the personal care of the Doctor who developed this
incredible medical breakthrough treatment. The treatment is an herbal
tablet taken over a period of several weeks and then once a week for
maintenance. The results of the tests are being monitored by the
developer and will be substantiated by their own personal physicians
in the U.S. upon their return.
During their absence, Mr. Brooks and Mr. Casad will be in regular
contact with HEE's Corporate Headquarters, and all new information
will be presented in future press releases as it is made available to
us.
Keep posted to our Web site for breaking news.

About HEE Corporation

The HEE Corporation was founded for the purpose of marketing a new
and extremely promising treatment for Type II Diabetes. HEE has
acquired the worldwide distribution rights for this diabetic
treatment. Just in the United States Type II Diabetes has reached
epidemic levels with 18.2 million confirmed cases and an estimated 5
million cases that are undiagnosed. Hundreds of billions of dollars
worldwide is spent each year on the treatment of this disease. For
more information about the Company contact Shannon Meyer at
620-663-3333 or visit our Web site at www.hee-corp.com.

NOTE: Safe Harbor for Forward-Looking Statements -- Except for
historical information contained herein, the statements in this news
release are forward-looking statements that are made pursuant to the
safe harbor provisions of the Private Securities Litigation Act of
1995. Forward-looking statements involve known and unknown risks and
uncertainties that may cause the company's actual results in the
future to differ materially from forecasted results. These risks and
uncertainties include, among other things, volatility of prices,
product demand, market compensation and risk inherent in the company's
international operations.

KEYWORD: INTERNATIONAL AFRICA/MIDDLE EAST KANSAS
INDUSTRY KEYWORD: MEDICAL BIOTECHNOLOGY
SOURCE: HEE Corp.

CONTACT INFORMATION:
HEE Corporation, Hutchinson
Shannon Meyer, 620-663-3333 www.hee-corp.com

------------------
Due Da Due......But Be Quick About It!!!!!

HEE Corporation Announces Update on Trial Treatment

***

Business Editors HUTCHINSON, Kan.--(BUSINESS WIRE)--HCCF-- HEE Corporation - (OTC - PK - HCCF) would like to provide an update on Ron Brooks and Stan Casad's treatments. They have now completed 4 days of treatments out of the eight weeks and the results to date are as follows: Both Ron Brooks's and Stan Casad's sugar levels have dropped substantially over the first four days the readings at 8:00 am each day are as follows: -0- *T Ron Brooks Stan Casad Arrival 231 215 Thursday June 24th Day 1 147 187 Friday June 25th Day 2 137 157 Saturday June 26th Day 3 141 198 Sunday June 27th Day 4 110 134 Monday June 28th *T Normal blood sugar levels for an adult male is approximately 90. Mr. Brooks had stopped taking his medication, for the control of his Type II Diabetes, upon his arrival. Prior to his arrival Mr. Brooks had been taking 45 Mg of Actos once a day and 12 Mg of Glyburide four times a day with food 30 minutes before eating to try and control the blood sugar in his body. Stan Casad had been managing his Diabetes through diet and other means and was never on any medication. This is incredibly significant as anyone with Type II Diabetes knows that up until now, the only effective way of controlling it was through medication usually using insulin. Both gentlemen are very encouraged and excited by the initial results and look forward to completing the treatment cycle. Mr. Brooks and Mr. Casad are under the personal care of the doctor who developed this incredible medical breakthrough treatment. Keep posted to our website for future developments on the treatment and further updates. ABOUT HEE CORPORATION The HEE Corporation was founded for the purpose of marketing a new and extremely promising treatment for Type II Diabetes. HEE has acquired the worldwide distribution rights for this diabetic treatment. Just in the United States type II Diabetes has reached epidemic levels with 18.2 million confirmed cases and an estimated 5 million cases that are undiagnosed. Hundreds of billions of dollars world wide is spent each year on the treatment of this disease. For more information about the Company contact Shannon @620-663-3333 or visit our web site at www.hee-corp.com. NOTE: Safe Harbor for Forward-Looking Statements--Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that may cause the company's actual results in the future to differ materially from forecasted results. These risks and uncertainties include, among other things, volatility of prices, product demand, market compensation and risk inherent in the company's international operations. KEYWORD: KANSAS INDUSTRY KEYWORD: CONSUMER/HOUSEHOLD CONSUMER/HOUSEHOLD CONSUMER/HOUSEHOLD MEDICAL EDUCATION CONSUMER/HOUSEHOLD CONSUMER/HOUSEHOLD CONSUMER/HOUSEHOLD PRODUCT SOURCE: HEE Corporation CONTACT INFORMATION: HEE Corporation Shannon Meyer, 620-663-3333 www.hee-corp.com

------------------

BANG!!!!! BEEN HOLDING SINCE THE 22ND WHEN BOUGHT AT 0.14...........JUST BUSTED UP 10,000 SHARES - 5000 AT 0.30 AND 5000 AT 0.32............$1700 BANK!!!!!

------------------
Due Da Due......But Be Quick About It!!!!!

------------------
Due Da Due......But Be Quick About It!!!!!

------------------
Due Da Due......But Be Quick About It!!!!!

Ruff

------------------
Due Da Due......But Be Quick About It!!!!!

------------------
Due Da Due......But Be Quick About It!!!!!

"just 7 months ago this stock was at $20 a share"

Investors need to be watching HEE Corporation (OTC: HCCF) today. HEE Corporation was founded for the purpose of marketing a new and extremely promising treatment for Type II Diabetes. This treatment was developed in South West Asia. HEE Corp. has acquired the worldwide distribution rights for this diabetic treatment. The company issued a press release this morning before the opening bell regarding an American doctor confirming interim treatment results. Mr. Brooks' and Mr. Casad's sugar levels are continuing to decline toward normal levels following their previous announcements of the results of the Type II diabetes treatments. This could be excellent news for investors!

Dr. Hemanth Reddy of Hutchinson, KS, -- Ron Brooks' personal physician for the past 5 years performed his own independent blood tests and the results astonished Dr. Reddy.

Dr. Reddy was amazed that Mr. Brooks' 30 day blood sugar average on July 6, 2004, was down to an incredible 141. Dr. Reddy was so impressed by this reduction in Mr. Brooks' blood sugar level, he requested that Mr. Brooks come back to do a follow up "fasting test" one week later. The follow up test was performed on Tuesday, July 13, 2004 and the results showed an even further 10 point drop in Mr. Brooks' 30 day blood sugar levels to 131.

Mr. Brooks' current fasting test shows a greater than 50% reduction in blood sugar levels. His 30 day average prior, was 280 which was done on June 22, 2004. This was the last time Mr. Brooks' tests were performed by Dr. Reddy before beginning the treatment.

Normal monitoring of Type II Diabetes is done on a quarterly basis throughout the year, with the fasting test giving a 30 day blood sugar average. This is not to be confused with the daily readings we have been reporting to the public. Mr. Brooks' daily blood sugar levels have been consistently in the low 90's for the past 13 days.

These results confirm that Mr. Brooks' treatments are being effective in reducing his blood sugar toward normal levels. As Mr. Brooks has been on the treatment for nearly three full weeks, his daily blood sugar levels are in the "normal acceptable range" for an adult male. Mr. Brooks has not been taking any other medication to control his blood sugar other than HEE Corporation's treatment. Although he has five more weeks until he completes the treatment cycle, the overall results in these first three weeks are nothing less then incredible.

Keep posted to our website for future developments on the treatment and further updates.

ABOUT HEE CORPORATION

The HEE Corporation was founded for the purpose of marketing a new and extremely promising treatment for Type II Diabetes. HEE has acquired the worldwide distribution rights for this diabetic treatment. Just in the United States type II Diabetes has reached epidemic levels with 18.2 million confirmed cases and an estimated 5 million cases that are undiagnosed. Hundreds of billions of dollars world wide is spent each year on the treatment of this disease.

Mr. Brooks' and Mr. Casad's sugar levels are continuing to decline toward "normal" levels following our previous announcements of the results of the Type II Diabetes treatments.

The latest blood sugar level counts are:

Ron BrooksStan Casad

7/07 92 123 Day 13
7/08 94 105 Day 14
7/09 91 110 Day 15
7/10 91 108 Day 16
7/11 93 87 Day 17
7/12 92 98 Day 18

6/24 231 215 Pre-Treatment Levels
=====================================================

HEE Corporation's Testing Continues to Show Positive Results

***

Health/Medical Writers / Business Editors HUTCHINSON, Kan.--(BUSINESS WIRE)--HCCF-- HEE Corporation - (OTC - PK - HCCF) announces that Ron Brooks and Stan Casad are into their 4th week of treatments. Both men are feeling wonderful and are in good physical condition. A main concern of both individuals before treatment was numbness in the feet and toes due to poor blood circulation, and all feeling has been regained. Mr. Brooks and Mr. Casad have not made any positive changes in their eating habits. They have reported eating many late night snacks including, but not limited to; milk shakes, ice cream sandwiches, soda pop, and assorted chocolates. The current eating habits of Mr. Brooks and Mr. Casad are consistent with their diet before treatment and are not that of a typical diabetic. People on this treatment are still encouraged to maintain healthy eating habits, however the blood sugar levels of these individuals continues to maintain despite their unhealthy diets. -0- *T UPDATED BLOOD SUGAR LEVELS ARE AS FOLLOWS: Ron Brooks Stan Casad 7/13 96 84 Day 19 7/14 94 105 Day 20 7/15 96 104 Day 21 7/16 88 115 Day 22 7/17 94 89 Day 23 7/18 96 * Day 24 7/19 94 102 Day 25 6/24 231 215 Before treatment * This number is waiting to be received from Mr. Casad's personal physician. *T Keep posted to our website for future developments on the treatment and further updates. ABOUT HEE CORPORATION The HEE Corporation was founded for the purpose of marketing a new and extremely promising treatment for Type II Diabetes. HEE has acquired the worldwide distribution rights for this diabetic treatment. Just in the United States type II Diabetes has reached epidemic levels with 18.2 million confirmed cases and an estimated 5 million cases that are undiagnosed. Hundreds of billions of dollars world wide is spent each year on the treatment of this disease. For more information about the Company contact Shannon @620-663-3333 or visit our web site at www.hee-corp.com. NOTE: Safe Harbor for Forward-Looking Statements--Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that may cause the company's actual results in the future to differ materially from forecasted results. These risks and uncertainties include, among other things, volatility of prices, product demand, market compensation and risk inherent in the company's international operations. KEYWORD: KANSAS INDUSTRY KEYWORD: CONSUMER/HOUSEHOLD CONSUMER/HOUSEHOLD CONSUMER/HOUSEHOLD PHARMACEUTICAL MEDICAL PHARMACEUTICAL MEDICAL SPORTS EDUCATION CONSUMER/HOUSEHOLD CONSUMER/HOUSEHOLD CONSUMER/HOUSEHOLD SOURCE: HEE Corporation CONTACT INFORMATION: HEE Corporation Shannon Meyer, 620-663-3333 www.hee-corp.com.

------------------
Due Da Due......But Be Quick About It!!!!!

Clarification Of Stock Dividend

Regarding the stock dividend declared on August 25, 2004 by Hee
Corporation, the Company wishes to correct an omission that was made
in the news release: The stock dividend consists of one (1)
non-transferable preferred share for each common share held on the
September 6, 2004 record date. Payment date of the dividend is
September 15, 2004. Each common shareholder's allotment (1-for-1) of
non-transferable preferred shares will automatically be mailed to all
common shareholders directly from the Company's transfer agent.
-0-
*T
TABLE OF 56-DAY TRIAL - Blood Sugar Levels

Date Ron Stan
---- --- ---
6/24 231 215 Arrival
6/25 147 187 Day 1
6/26 137 157 Day 2
6/27 141 198 Day 3
6/28 110 134 Day 4
6/29 105 134 Day 5
6/30 103 122 Day 6
7/01 96 118 Day 7
7/02 96 108 Day 8
7/03 96 124 Day 9
7/04 94 146 Day 10
7/05 96 118 Day 11
7/06 94 137 Day 12
7/07 92 123 Day 13
7/08 94 105 Day 14
7/09 91 110 Day 15
7/10 91 108 Day 16
7/11 93 87 Day 17
7/12 92 98 Day 18
7/13 96 84 Day 19
7/14 94 105 Day 20
7/15 96 104 Day 21
7/16 88 115 Day 22
7/17 94 89 Day 23
7/18 96 N/A Day 24
7/19 94 102 Day 25
7/20 92 109 Day 26
7/21 96 97 Day 27
7/22 88 95 Day 28
7/23 96 114 Day 29
7/24 92 102 Day 30
7/25 94 93 Day 31
7/26 91 107 Day 32
7/27 93 80 Day 33
7/28 91 84 Day 34
7/29 92 80 Day 35
7/30 93 87 Day 36
7/31 93 84 Day 37
8/01 91 97 Day 38
8/02 93 94 Day 39
8/03 92 96 Day 40
8/04 94 94 Day 41
8/05 90 89 Day 42
8/06 91 108 Day 43
8/07 97 113 Day 44
8/08 92 133 Day 45
8/09 91 122 Day 46
8/10 89 139 Day 47
8/11 92 114 Day 48
8/12 94 120 Day 49
8/13 92 109 Day 50
8/14 93 107 Day 51
8/15 94 108 Day 52
8/16 93 112 Day 53
8/17 96 116 Day 54
8/18 88 114 Day 55
8/19 94 114 Day 56

N/A - Not available
*T
This ends the initial 8-week trial. Mr. Casad's levels increased
at Day 43 because he had to decrease treatment due to losing a
substantial amount of the treatment. His levels stayed surprisingly
lower even when treatment doses were unavoidably decreased early. Both
subjects have continued their normal eating habits. Results will
continue to be charted, and will be incorporated into the trial's
final results and conclusions.

About Hee Corporation

The HEE Corporation was founded for the purpose of testing and
marketing a new and extremely promising homeopathic treatment for Type
II Diabetes. HEE has acquired the worldwide distribution rights for
this diabetic treatment. In the United States alone, 18.2 million
people have diabetes and, unfortunately, 5.2 million (nearly one-third
of that total) are not yet aware that they have it! Diabetes is the
fifth leading cause of death by disease in the US. Now a modern-day
epidemic, some 171,000,000 people around the globe are estimated to
have diabetes (mostly Type II) and the costs of treatment and
productivity losses now run into the hundreds of billions of dollars
worldwide.

NOTE: Safe Harbor for Forward-Looking Statements--Except for
historical information contained herein, the statements in this news
release are forward-looking statements that are made pursuant to the
safe harbor provisions of the Private Securities Litigation Act of
1995. Forward-looking statements involve known and unknown risks and
uncertainties that may cause the company's actual results in the
future to differ materially from forecasted results. These risks and
uncertainties include, among other things, volatility of prices,
product demand, market compensation and risk inherent in the company's
international operations.

KEYWORD: KANSAS
INDUSTRY KEYWORD: BANKING BANKING MEDICAL PHARMACEUTICAL MEDICAL PHARMACEUTICAL MEDICAL PHARMACEUTICAL ALTERNATIVE MEDICINE DIVIDEND
SOURCE: HEE Corporation

CONTACT INFORMATION:
HEE Corporation
Shannon Meyer, 620-663-3333 www.hee-corp.com

------------------
You Must Adapt To Your Opportunities And Weaknesses. You Can Use A Variety Of Approaches And Still Have A Consistant Result. - Sun Tzu, "The Art Of War"

Do Da Due.....But Be Damn Quick About It. - Dardadog, "Da Art Of Daytrading"

------------------
You Must Adapt To Your Opportunities And Weaknesses. You Can Use A Variety Of Approaches And Still Have A Consistant Result. - Sun Tzu, "The Art Of War"

Do Da Due.....But Be Damn Quick About It. - Dardadog, "Da Art Of Daytrading"

Monty,

We don't believe we are going to have to have FDA approval because this is a
homeopathic treatment. We have no answers about the volume. Your guess is
as good as ours! Keep checking out the website for further updates! We
have our new website up and we are adding more information all the time.

Thank you,

HALSTEAD HOSPITAL AND THE HERTZLER CLINIC

Founded in 1902 by the famous "horse and buggy" doctor, Dr. A. E. Hertzler, the Halstead Hospital and adjoining Hertzler Clinic grew to become a comprehensive, JCAHO-accredited hospital. It was an acute-care medical, surgical and psychiatric facility also providing the full array of cardiology and oncology. The adjoining Hertzler Clinic was staffed primarily with primary care and specialty physicians. Employing more than 300 full and part-time health care professionals, and with 24-hour ER service, the hospital was known far and wide throughout Kansas and neighboring states for its excellent healthcare services and, in the latter half of the century, gained a reputation as the "Little Mayo Clinic of the Midwest".

About HEE Corporation

An emerging growth healthcare company, the HEE Corporation was initially founded for the purpose of testing and marketing a new and extremely promising homeopathic treatment for Type II Diabetes. HEE has acquired the worldwide distribution rights for this diabetic treatment. In the United States alone, 18.2 million people have diabetes and, unfortunately, 5.2 million (nearly one-third of that total) are not yet aware that they have it! Diabetes is the fifth leading cause of death by disease in the US. Now a modern-day epidemic, some 171,000,000 people around the globe are estimated to have diabetes (mostly Type II) and the costs of treatment and productivity losses now run into the hundreds of billions of dollars worldwide. Early indications from the Company's current phase of treatment and testing have been extremely positive, holding out great promise that a cure for Type II diabetes may be in sight. Acquisition of the Halstead Hospital and Hertzler Clinic represents an important step forward in Hee Corp's growth plans in the dynamic, multibillion-dollar healthcare industry.

Looks like another good move.

Health/Medical Writers / Business Editors

HUTCHINSON, Kan.--(BUSINESS WIRE)--HCCF--
HEE Corporation ('HCCF' on OTC Pink Sheets) is pleased
to report that the results of a Hemoglobin A1c Test (HbA1c) conducted
on test subject Ron Brooks on September 8, 2004, were excellent. The
HbA1c test, which most physicians regard as the most dependable
measure of a patient's blood sugar level, provides an accurate blood
sugar average over a 90-day period, and is the most comprehensive and
representative reading of an individual's overall blood sugar level.
Mr. Brooks' blood sugar reading on the September 8th test was an
astounding 6.7%, down significantly from his August 3, 2004 reading of
7.5%, and exceeding by a very comfortable margin the common goal of
achieving a reading of less than 7%. Ron Brooks continues, of course,
to take a maintenance dose of the Company's Type II Diabetes
treatment. Coupled with the extraordinary improvement in both test
subjects' daily blood sugar levels during the eight-week treatment
period, Mr. Brook's latest HbA1c test reinforces the very positive
interim results of the 8-week trial, and serves to enhance the promise
that has been clearly demonstrated to date by HEE Corp's homeopathic
treatment for Type II Diabetes.

HEE Launches New Website

HEE Corp. is also proud to announce the launch of its new, more
comprehensive, yet user-'friendlier' website which provides extensive
information concerning Type II Diabetes, as well as timely information
on HEE's corporate activities. The site offers valuable Investor
Relations information, including a link to live stock quotes, and has
a Media Section that archives corporate News Releases and Media
Interviews with management. This Media Section will be expanded over
time to include forthcoming TV interviews with HEE Corp. management,
pertinent Newspaper articles, etc. The recent interview with "It's
About Finance.com" filmed on the floor of the Chicago Stock Exchange
is currently on the new website. We urge interested parties to visit
the site often to keep abreast of HEE Corporation developments,
including additional test results during this very exciting period in
the Company's development.

About HEE Corporation

An emerging-growth healthcare company, the HEE Corporation was
initially founded for the purpose of testing and marketing a new and
extremely promising homeopathic treatment for Type II Diabetes. HEE
has acquired the worldwide distribution rights for this diabetic
treatment. In the United States alone, 18.2 million people have
diabetes and, unfortunately, 5.2 million (nearly one-third of that
total) are not yet aware that they have it! Diabetes is the fifth
leading cause of death by disease in the US. Now a modern-day
epidemic, some 171,000,000 people around the globe are estimated to
have diabetes (mostly Type II) and the costs of treatment and
productivity losses now run into the hundreds of billions of dollars
worldwide. Early indications from the Company's current phase of
treatment and testing have been extremely positive, holding out great
promise that a cure for Type II Diabetes may be in sight. The recently
announced acquisition of the Halstead Hospital and Hertzler Clinic in
Kansas represents another important step forward in HEE Corp's growth
plans in the dynamic, multibillion-dollar healthcare industry.

NOTE: Safe Harbor for Forward-Looking Statements--Except for
historical information contained herein, the statements in this news
release are forward-looking statements that are made pursuant to the
safe harbor provisions of the Private Securities Litigation Act of
1995. Forward-looking statements involve known and unknown risks and
uncertainties that may cause the company's actual results in the
future to differ materially from forecasted results. These risks and
uncertainties include, among other things, volatility of prices,
product demand, market compensation and risk inherent in the company's
international operations.

KEYWORD: KANSAS
INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL MEDICAL E-COMMERCE INTERNET PRODUCT
SOURCE: HEE Corporation

CONTACT INFORMATION:
HEE Corporation
Shannon Meyer, 620-663-3333 www.hee-corp.com